Skip to main content Skip to footer

Press Releases

Bringing Science to Society™

Investors

Investors

  • Overview
  • Press Releases
  • Investor Events
  • Presentations
  • Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • Stock Information
    • Quote
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
Mar 27, 2018 7:00am EDT

Recro Pharma Announces Publication of Phase III IV Meloxicam Bunionectomy Data in the Clinical Journal of Pain

Mar 21, 2018 7:00am EDT

Recro Pharma to Present at the 17th Annual Needham Healthcare Conference

Mar 06, 2018 7:00am EST

Recro Pharma to Present at Upcoming Investor Conferences

Mar 05, 2018 7:00am EST

Recro Pharma Announces an Educational Symposium on Challenges in Acute Pain Management and Advances in Evidence-Based Management Approaches at the American Academy of Orthopaedic Surgeons 2018 Annual Meeting

Mar 02, 2018 4:05pm EST

Recro Pharma Announces Commercial Team Additions

Feb 27, 2018 7:00am EST

Recro Pharma Reports Year End 2017 Financial Results

Feb 21, 2018 7:00am EST

Recro Pharma to Host Analyst and Investor Day on February 28, 2018

Feb 20, 2018 7:00am EST

Recro Pharma Announces Publication of Supportive Phase II IV Meloxicam Bunionectomy Data in the Journal of Pain Research

Feb 02, 2018 7:00am EST

Recro Pharma Announces Key Sales Team Additions

Jan 17, 2018 8:45am EST

Recro Pharma Announces Publication of Supportive Phase II IV Meloxicam Data in the Journal of Clinical Pharmacology

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • …
  • Page 24
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Copyright ©2023 Societal CDMO. All rights reserved. Manage Cookie Preferences
Follow us